Get started
LUPIN LTD.LUPIN LTD.LUPIN LTD.

LUPIN LTD.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

LUPIN trade ideas

📈 Navigating Lupin: Seizing the 75-Minute Demand Zone!Embark on a strategic journey through Lupin's charts, revealing a promising trade opportunity in simple terms suitable for traders of all levels. Current Market Position 📊: LTF (75 min): Lupin is firmly situated within the 75-minute demand zone, specifically at the bottom and exhibiting a very inside structure. ITF (Daily): Confirming the bullish sentiment, Lupin is comfortably nestled in the daily demand zone, signalling a favourable environment. HTF (Weekly): On the weekly chart, supply zone is very far, and price is trading at fair location, providing a conducive backdrop for potential upward movements. Trade Strategy 📈: Entry: Plan a buy entry at the current market price. Stop Loss (SL): Set the stop-loss just below the 75-minute demand zone, introducing a slight buffer around 1180. Target: Aim for levels below the 75-minute supply zone, approximately around 1215. Entry Price: Consider entering at the current market price of 1194. Why Lupin Presents an Opportunity 🌟: Demand Zone Alignment: Lupin is strategically positioned in both the 75-minute and daily demand zones. Trend Observation: The daily sideways trend, combined with proximity to the 20EMA, indicates favourable conditions for a potential bullish move. Weekly Outlook: supply zone is very far on the weekly chart adds strength to the potential trade. Final Trade Thoughts 🚀: Lupin's current scenario isn't just an opportunity; it's a strategic move. With a keen focus on demand zones, and favourable weekly conditions, this trade deserves attention. Trade Smart, Trade Confidently! 💹✨ Disclaimer 🚨: This analysis is for educational purposes only. I am not a SEBI registered analyst. Trade responsibly.
NSE:LUPINLong
by AfnanTAjuddin
hedge strategy in $NSE:LUPIN Dear Followers, I hope you're doing well. I wanted to share a brief update regarding the short-term trend of the stock NSE:LUPIN I have been monitoring. Currently, the stock is experiencing a downtrend in its short-term price movement. My analysis indicates that market conditions and recent price action suggest a period of declining prices. This information could potentially be useful for your investment / hedge strategy. If Stock Break 1210-1200 level then possibly we can see 1170 level so if you are ready to take Risk then I have 2 Strategies For Month Of November Series that we can Deploy. 1) Buying an Option Strike Rate= 1220 PE Buy Price= 26-27 Stop Loss= 20 Target = 40,50 Time Frame 7-8 Days Investment = 22500 maximum Loss= 5100 Profit Upto = 20000 2) Hedge strategy NSE:LUPIN1! Future Entry Level - Sell 1223-1225 Future Stop Loss Level- 1240 Future Target Level- 1200,1190 Option Level- Buy 1220 CE Investment = 45000 Maximum Loss = 12000 Profit Upto = 23000 Best Regards,
NSE:LUPINShort
by PrachiMetha
LUPIN - Stock AnalysisLupin Ltd. is showing a strong technical and fundamental profile, making it an interesting prospect for investors. From a technical perspective, the stock exhibits several "Strong Bullish" signals. The HighLow indicator suggests "Strong Bullish" sentiment, with the stock near a one-year high and likely to make a new high. The daily candlestick pattern reflects "Strong Bullish" sentiment, and the monthly candlestick pattern also displays "Strong Bullish" signals. In terms of resistance, the stock has encountered medium-term resistance levels, with top points at 1200.0 on October 19, 2023, 1174.2 on October 3, 2023, and 1155.65 on September 14, 2023. From a fundamental perspective, Lupin Ltd. has several positive attributes. The company's net profit has seen a significant turnaround, shifting from negative to positive, indicating an improved financial performance. The Piotroski F Score is at a stable value of 5.0, which suggests sound financial health. Furthermore, the company's net profit has been consistently increasing for the last five quarters, and the same holds for Profit Before Tax, demonstrating strong operational performance. There has been steady growth in earnings per share (EPS) over the last four quarters. Lupin Ltd. offers a very low dividend yield of 0.350%, indicating a preference for reinvesting profits for growth. Additionally, there is a short-term positive trend in total sales and net profit. The company has achieved annual sales growth for three consecutive years, and quarterly sales over the last five years are trending upward. In summary, Lupin Ltd. presents a promising investment opportunity with strong technical and fundamental indicators. The stock's bullish technical signals, coupled with its improving financial performance and consistent growth, make it an attractive choice for investors seeking potential growth and value in the market. Nevertheless, investors should stay vigilant and monitor developments in both technical and fundamental aspects for a comprehensive understanding of the stock's potential. Go Long above 1184.10 Stop Loss 1095
NSE:LUPINLong
by ruelfernandes
NSE:Lupin -trend change on card??? NSE:LUPIN Lupin Limited is an India-based pharmaceutical company. The Company develops and commercializes a range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) in over 100 markets in the United States, India, South Africa, and across the Asia Pacific, Latin America, and others. It offers vitamins, minerals, supplements and neurological products. It has presence in the cardiovascular, dialectology, asthma, paediatrics, central nervous system, gastro-intestinal, anti-infectives and nonsteroidal anti-inflammatory drug therapy segments. Its complex generics portfolio includes Filgrastim, Peg-Filgrastim, Etanercept and Albuterol, and others. Its biosimilar products include Filgrastim, Peg-Filgrastim and Etanercept. Its specialty products consist of Solosec and NaMuscla. Its over-the-counter products include Softovac, Lupizyme, Aptivate, Lupisafe, Be One, V-Bath, and others. It supplies APIs for anti-retroviral, anti-malarial and others. Disc: Invested, please do you own research
NSE:LUPIN
by Peaceful-Weekend-Investing
Long Swing Trade on Lupin (LUPIN)Trade Thesis: I'm taking a long position on Lupin (LUPIN) for swing trading. My rationale is based on a combination of technical and fundamental factors. Technical Analysis: The stock has recently broken out of a strong resistance level, indicating potential bullish momentum. The Moving Averages (e.g., 50-day and 200-day) are converging, which is often a bullish signal. The Relative Strength Index (RSI) is showing strength and is not in overbought territory. Fundamental Analysis: Lupin is a pharmaceutical company with a solid track record and a diversified product portfolio. The healthcare sector, in general, has been showing resilience and growth potential. Lupin's recent earnings and revenue reports have been positive, suggesting strong fundamentals. Risk Management: I'll be implementing a stop-loss at a level that aligns with my risk tolerance. Position sizing will be in line with my overall portfolio strategy. Target Price: My initial target price is , with room to adjust as the trade progresses. Disclaimer: This analysis is for informational purposes only and should not be considered financial advice. Always do your own research and consult with a financial advisor before making trading decisions.
NSE:LUPINLong
by potatowada